Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues.: 1.: Derivatives substituted at the carbon atoms of the base

被引:175
作者
Holy, A
Günter, J
Dvoráková, H
Masojídková, M
Andrei, G
Snoeck, R
Balzarini, J
De Clercq, E
机构
[1] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague 6, Czech Republic
[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Leuven, Belgium
关键词
D O I
10.1021/jm9811256
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of dialkyl esters of purine and pyrimidine N-[2-(phosphonomethoxy)ethyl] derivatives substituted at position 2, 6, or 8 of the purine base or position 2, 4, or 5 of the pyrimidine base were prepared by alkylation of the appropriate heterocyclic base with 2-chloroethoxymethylphosphonate diester in the presence of sodium hydride, cesium carbonate, or 1,8-diazabicyclo-[5,4,0]undec-7-ene (DBU) in dimethylformamide. Additional derivatives were,obtained by the transformations of the bases in the suitably modified intermediates bearing reactive functions at the base moiety. The diesters were converted to the corresponding monoesters by sodium azide treatment, while the free acids were obtained from the diester by successive treatment with bromotrimethylsilane and hydrolysis. None of the PME derivatives in the pyrimidine series, their 6-aza or 3-deaza analogues, exhibited any activity against DNA viruses or retroviruses tested,except for the 5-bromocytosine derivative. Substitution of the adenine ring in PMEA at position 2 by Cl, F, or OH group decreased the activity against all DNA viruses tested. PMEDAP was highly active against HSV-1, HSV-8, and VZV in the concentration range (EC50) of 0.07-2 mu g/mL. Also the 2-amino-6-chloropurine derivative was strongly active (EC50 = 0.1-0.4 mu g/mL) against herpes simplex viruses and (EC50 = 0.006-0.3 mu g/mL) against CMV and VZV. PMEG was the most active compound of the whole series: against DNA viruses (EC50 similar to 0.01-0.02 mu g/mL), though it exhibited significant toxicity against the host cells. The base-modified compounds did not show any appreciable activity against DNA viruses except for 7-deazaPMEA (IC50 similar to 7.5 mu g/mL) against HIV-1 and MSV. The neutral.(diisopropyl, diisooctyl) diesters of PMEA were active against CMV and VZV, while the corresponding monoesters were inactive. The diisopropyl ester of the 2-chloroadenine analogue of PMEA showed substantially (10-100x) higher activity against CMV and VZV than the parent phosphonate. Also, the diisopropyl and diisooctyl ester of PMEDAP inhibited CMV sind VZV, but esterification of the phosphonate residue did not improve the activity against either MSV or. HIV.
引用
收藏
页码:2064 / 2086
页数:23
相关论文
共 122 条
[1]   Synthesis and antiviral activity of pyranosylphosphonic acid nucleotide analogues [J].
Alexander, P ;
Krishnamurthy, VV ;
Prisbe, EJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (06) :1321-1330
[2]   PRODRUGS OF ANALOGS OF NUCLEIC-ACID COMPONENTS [J].
ALEXANDER, P ;
HOLY, A .
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1994, 59 (10) :2127-2165
[3]  
ARNOLD Z, 1964, COLLECT CZECH CHEM C, V29, P645
[4]   INVITRO ACTIVITY OF (S)-9-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)-ADENINE AGAINST NEWLY ISOLATED CLINICAL VARICELLA-ZOSTER VIRUS-STRAINS [J].
BABA, M ;
KONNO, K ;
SHIGETA, S ;
DECLERCQ, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (02) :158-160
[5]   MARKED INVIVO ANTIRETROVIRUS ACTIVITY OF 9-(2-PHOSPHONYLMETHOXY-ETHYL)ADENINE, A SELECTIVE ANTI-HUMAN IMMUNODEFICIENCY VIRUS AGENT [J].
BALZARINI, J ;
NAESENS, L ;
HERDEWIJN, P ;
ROSENBERG, I ;
HOLY, A ;
PAUWELS, R ;
BABA, M ;
JOHNS, DG ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) :332-336
[6]  
BALZARINI J, 1991, J BIOL CHEM, V266, P8686
[7]   INTRACELLULAR METABOLISM AND MECHANISM OF ANTIRETROVIRUS ACTION OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, A POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS COMPOUND [J].
BALZARINI, J ;
ZHANG, H ;
HERDEWIJN, P ;
JOHNS, DG ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1499-1503
[8]   9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE (PMEA) EFFECTIVELY INHIBITS RETROVIRUS REPLICATION INVITRO AND SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN RHESUS-MONKEYS [J].
BALZARINI, J ;
NAESENS, L ;
SLACHMUYLDERS, J ;
NIPHUIS, H ;
ROSENBERG, I ;
HOLY, A ;
SCHELLEKENS, H ;
DECLERCQ, E .
AIDS, 1991, 5 (01) :21-28
[9]   COMPARATIVE ANTIRETROVIRUS AND ANTI-HEPADNAVIRUS ACTIVITY OF 3 DIFFERENT CLASSES OF NUCLEOSIDE PHOSPHONATE DERIVATIVES [J].
BALZARINI, J ;
KRUINING, J ;
HEIJTINK, R ;
DECLERCQ, E .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1994, 5 (06) :360-365
[10]   THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INHIBITOR 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE (PMEA) IS A STRONG INDUCER OF DIFFERENTIATION OF SEVERAL TUMOR-CELL LINES [J].
BALZARINI, J ;
VERSTUYF, A ;
HATSE, S ;
GOEBELS, J ;
SOBIS, H ;
VANDEPUTTE, M ;
DECLERCQ, E .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (01) :130-137